Investigation of PLGF, sFlt-1 Expression in Placenta Previa, Placenta Accreta and Normotensive Placentas in the 3rd Trimester of Pregnancy
dc.contributor.author | Erdoğan, Gamze | |
dc.contributor.author | Kaya, Seval | |
dc.contributor.author | Peker, Nurullah | |
dc.contributor.author | İbiloğlu, İbrahim | |
dc.contributor.author | Deveci, Engin | |
dc.date.accessioned | 2025-02-22T14:13:32Z | |
dc.date.available | 2025-02-22T14:13:32Z | |
dc.date.issued | 2024 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Background: We aimed to immunohistochemically examine the expression level of Placental growth factor (PLGF) and Soluble FMS-like tyrosine kinase-1 (sFlt-1) proteins in normotensive, Placenta accreta (PA) and Placenta previa (PP). Materials and Methods: Three groups were created for the study: 20 Nomotensive placentas, 20 PP and 20 PA from women diagnosed with placenta samples. 4-6 μm thick sections were taken from the placentas, PLGF and sFlt-1 immunostaining were applied to the obtained sections, and their expression intensities and localizations in the tissues were determined. Results: As a result of our observations, normotensive placenta group; sFlt-1 expression was observed in hofbauer cells and syncytial nodes and PLGF positive expression was observed in nuclei of muscle cells in some tunica media region. PP and PA group; sFlt-1 expression was positive in decidua cells, hofbauer cells and dilated vascular endothelium. PP and PA group; negative PLGF expression was observed in syncytial nodes and positive PLGF expression was observed in hofbauer cells and endothelial cells. There was a significant difference between normotensive, PP and PA groups (p<0.05). Conclusions: It can be thought that sFlt-1 and PLGF may be important signal stimulators and markers in the trophoblastic degeneration, apoptotic cells, increase in angiogenesis and imbalance in implanta-tion seen in cases of PP and PA. | en_US |
dc.identifier.doi | 10.35440/hutfd.1487194 | |
dc.identifier.endpage | 414 | en_US |
dc.identifier.issn | 1304-9623 | |
dc.identifier.issn | 1309-4025 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 407 | en_US |
dc.identifier.trdizinid | 1289399 | en_US |
dc.identifier.uri | https://doi.org/10.35440/hutfd.1487194 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1289399 | |
dc.identifier.uri | https://hdl.handle.net/11468/30054 | |
dc.identifier.volume | 21 | en_US |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Harran Üniversitesi Tıp Fakültesi Dergisi | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KA_TR_20250222 | |
dc.subject | SFlt-1 | en_US |
dc.subject | Placenta previa | en_US |
dc.subject | Placenta accreta | en_US |
dc.subject | PLGF | en_US |
dc.title | Investigation of PLGF, sFlt-1 Expression in Placenta Previa, Placenta Accreta and Normotensive Placentas in the 3rd Trimester of Pregnancy | en_US |
dc.type | Article | en_US |